Ernexa Therapeutics ERNA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.20 | 139.51 | -0.01 | -2,094 | -2 | |
| 2025Q3 | 1.10 | 157.50 | 0.38 | -1,994 | -1 | |
| 2025Q2 | 1.84 | 79.75 | -0.36 | -2,501 | -3 | |
| 2025Q1 | 2.67 | 33.30 | -2.25 | -2,730 | -8 | |
| 2024Q4 | 4.41 | 119.07 | 58.49 | -2,697 | -6 | |
| 2024Q3 | 15.75 | 9.07 | -73.70 | -2,259 | -27 | |
| 2024Q2 | 27.45 | 104.27 | -15.30 | -4,931 | -6 | |
| 2024Q1 | 36.00 | 98.80 | -18.45 | -5,787 | -7 | |
| 2023Q4 | 26.93 | 102.38 | -17.10 | -5,765 | -6 | |
| 2023Q3 | 32.70 | 98.76 | -15.60 | -5,505 | -6 | |
| 2023Q2 | 33.90 | 101.02 | -12.60 | -4,549 | -5 | |
| 2023Q1 | 51.00 | 98.24 | -15.90 | -5,316 | -5 | |
| 2022Q4 | 48.30 | 106.47 | -15.30 | -4,737 | -4 | |
| 2022Q3 | 2181.00 | 113.57 | -37.35 | -8,304 | -7 | |
| 2022Q2 | 2382.00 | 408.48 | -15.75 | -13,880 | -3 | |
| 2022Q1 | 3417.00 | 67.16 | -52.50 | -6,296 | -9 | |
| 2021Q4 | 4362.00 | 108.04 | 2.70 | -8,522 | -8 |